Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 403 | 325 | 288 | 325 | 314 |
| Operating Income | -403 | -325 | -288 | -325 | -314 |
| Other Income | 252 | 255 | 2,100 | 3,197 | 2,544 |
| Pre-tax Income | -151 | -69 | 1,812 | 2,872 | 2,230 |
| Net Income Continuous | -151 | -69 | 1,812 | 2,872 | 2,230 |
| Net Income | $-151 | $-69 | $1,812 | $2,872 | $2,230 |
| EPS Basic Total Ops | 72.07 | N/A | 108.11 | 96.10 | 108.11 |
| EPS Basic Continuous Ops | 913.38 | N/A | 579.83 | 480.05 | 372.71 |
| EPS Diluted Total Ops | 72.07 | N/A | 108.11 | 96.10 | 108.11 |
| EPS Diluted Continuous Ops | 913.38 | N/A | 579.83 | 480.05 | 372.71 |
| EBITDA(a) | $-403 | $-325 | $-288 | $-325 | $-314 |